Related Experiment Video
Updated: Apr 17, 2026

Cell-Specific Paired Interrogation of the Mouse Ovarian Epigenome and Transcriptome
Published on: February 24, 2023
Induction of PLSCR1 in a STING/IRF3-dependent manner upon vector transfection in ovarian epithelial cells
Karthik M Kodigepalli1, Meera Nanjundan1
1Department of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, Florida, 33620, United States of America.
Abstract:
Toll-like receptors (TLRs) are the primary sensors of the innate immune system that recognize pathogenic nucleic acids including double-stranded plasmid DNA (dsDNA). TLR signaling activates multiple pathways including IRF3 which is involved in transcriptional induction of inflammatory cytokines (i.e. interferons (IFNs)). Phospholipid scramblase 1, PLSCR1, is a highly inducible IFN-regulated gene mediating anti-viral properties of IFNs. Herein, we report a novel finding that dsDNA transfection in T80 immortalized normal ovarian surface epithelial cell line leads to a marked increase in PLSCR1 mRNA and protein. We also noted a comparable response in primary mammary epithelial cells (HMECs). Similar to IFN-2α treated cells, de novo synthesized PLSCR1 was localized predominantly to the plasma membrane. dsDNA transfection, in T80 and HMEC cells, led to activation of MAPK and IRF3. Although inhibition of MAPK (using U0126) did not modulate PLSCR1 mRNA and protein, IRF3 knockdown (using siRNA) significantly ablated the PLSCR1 induction. In prior studies, the activation of IRF3 was shown to be mediated by cGAS-STING pathway. To investigate the contribution of STING to PLSCR1 induction, we utilized siRNA to reduce STING expression and observed that PLSCR1 protein was markedly reduced. In contrast to normal T80/HMECs, the phosphorylation of IRF3 as well as induction of STING and PLSCR1 were absent in ovarian cancer cells (serous, clear cell, and endometrioid) suggesting that the STING/IRF3 pathway may be dysregulated in these cancer cells. However, we also noted induction of different TLR and IFN mRNAs between the T80 and HEY (serous epithelial ovarian carcinoma) cell lines upon dsDNA transfection. Collectively, these results indicate that the STING/IRF3 pathway, activated following dsDNA transfection, contributes to upregulation of PLSCR1 in ovarian epithelial cells.
Insights
Double-stranded DNA triggers the STING/IRF3 pathway in ovarian cells, increasing PLSCR1 expression. This pathway is dysregulated in ovarian cancer cells, suggesting a potential role in disease progression.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Toll-like receptors (TLRs) sense pathogenic nucleic acids, initiating innate immune responses.
- Interferon (IFN)-regulated genes, like Phospholipid scramblase 1 (PLSCR1), mediate antiviral functions.
- PLSCR1 is induced by IFNs and plays a role in antiviral defense.
Purpose of the Study:
- To investigate the effect of double-stranded DNA (dsDNA) transfection on PLSCR1 expression in ovarian epithelial cells.
- To elucidate the signaling pathways involved in dsDNA-induced PLSCR1 upregulation.
- To determine if this pathway is altered in ovarian cancer cells.
Main Methods:
- dsDNA transfection of normal ovarian surface epithelial cells (T80) and primary mammary epithelial cells (HMECs).
- Analysis of PLSCR1 mRNA and protein levels, cellular localization.
- Investigation of MAPK and IRF3 activation using inhibitors and siRNA.
- Assessment of the cGAS-STING pathway involvement via STING knockdown.
- Comparison of responses in normal cells versus ovarian cancer cell lines.
Main Results:
- dsDNA transfection significantly increased PLSCR1 mRNA and protein in T80 and HMEC cells.
- PLSCR1 induction was dependent on IRF3 and STING activation, not MAPK.
- Normal ovarian epithelial cells showed dsDNA-induced STING/IRF3 activation and PLSCR1 upregulation.
- Ovarian cancer cell lines lacked IRF3 phosphorylation, STING induction, and PLSCR1 upregulation upon dsDNA transfection.
Conclusions:
- The STING/IRF3 pathway is activated by dsDNA and contributes to PLSCR1 induction in normal ovarian epithelial cells.
- Dysregulation of the STING/IRF3 pathway is observed in ovarian cancer cells, indicating a potential link to disease.
- PLSCR1 induction by dsDNA represents a novel innate immune response mechanism in ovarian epithelium.

